AIBT logo

AIBT Aibotics Inc.

Other OTC · Medical - Pharmaceuticals · Healthcare

$0.00
-0.00 (-3.33%)

Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Flo…

Market Cap: $2.58Maibotics.ai

Price

No data yet.

Social Signal Score

43
5d
—
30d
45
4 mentions
—
60d
42
5 mentions
—
90d
42
5 mentions
—
news: 5

Revenue

$0.00-100.00%
$-10.41M$-5.31M$-207.1K$4.90M
Sep 2017Sep 2026

Company Profile

CEO
Benjamin Kaplan
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
1
Beta
1.34
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-67.59
aibotics.ai